Isoptin

Verapamil, the active ingredient in Isoptin, is a calcium channel blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure, relieve chest pain from angina, and control certain cardiac rhythm disorders in adult patients.

GNH USA supplies Isoptin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Clients benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

Isoptin (verapamil) acts on the cardiovascular system to lower blood pressure, relieve angina, and stabilize heart rhythm.

Hypertension: reduces systemic vascular resistance and lowers arterial pressure. Angina pectoris: decreases myocardial oxygen demand by reducing cardiac contractility and heart rate. Cardiac arrhythmias: slows conduction through the atrioventricular node to control supraventricular tachycardia.

Verapamil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Constipation - Dizziness - Headache - Flushing - Peripheral edema - Nausea

Serious or Rare Side Effects: - Severe bradycardia - Heart block - Marked hypotension - Atrioventricular conduction disturbances - Allergic reactions - Elevated liver enzymes

Before prescribing Isoptin, clinicians should consider several safety measures. - Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess cardiac function: evaluate for existing conduction abnormalities. - Review concomitant beta‑blocker therapy: combined use may increase bradycardia risk. - Use with caution in hepatic impairment: dose adjustment may be required. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Store at room temperature: keep in the original pack, protect from moisture.

Verapamil can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Diltiazem: additive cardiac depressant effects. - Beta‑blockers: increased risk of bradycardia and AV block. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise verapamil plasma levels.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce antihypertensive efficacy. - Statins: potential for increased statin concentrations.